Compare Graham Holdings Company Common Stock (GHC) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Graham Holdings Company Common Stock vs State Street SPDR S&P Biotech ETF — how do they compare? Graham Holdings Company Common Stock trades at $1,186.01 (market cap $5.02B), while State Street SPDR S&P Biotech ETF trades at $147.19 (market cap $10.05B). The key difference: State Street SPDR S&P Biotech ETF is far larger — about 2× Graham Holdings Company Common Stock's market cap, and Graham Holdings Company Common Stock pays a 0.63% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Graham Holdings Company Common Stock for 0 Days and State Street SPDR S&P Biotech ETF for 39 Days on average.
| GHC | XBI | |
|---|---|---|
Market Cap | $5.02B | $10.05B |
Volume | 21,118 | 10,367,649 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $1.23K | $169.55 |
52-Week Low | $949.84 | $107.32 |
Typical Hold Time | 0 Days | 39 Days |
Enterprise Value | $5.12B | — |
Dividend Yield | 0.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $146.8, down 3.04% today, with a bearish technical signal driven by selling pressure in moving averages. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts. Recent news highlights sector optimism from cancer vaccine breakthroughs and improved capital access, though the ETF carries higher volatility than diversified healthcare funds.
Outlook remains mixed with neutral analyst consensus but positive sector catalysts. Opportunities include biotech innovation and M&A potential, while risks involve high volatility, regulatory uncertainty, and expense ratios above broader healthcare ETFs. Investors should weigh targeted biotech exposure against sector-wide stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Graham Holdings Company Common Stock
Graham Holdings Company is a diversified holding company with operations spanning education services (Kaplan), television broadcasting (Graham Media Group), healthcare services, and manufacturing, among other businesses; it was formerly known as The Washington Post Company.
Read more on GHC →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
